Patients with mild to moderate Alzheimer's disease who took omega-3 fatty acid docosahexaenoic acid (DHA) supplements did not experience a slowing of brain decline compared with patients who took a placebo, says lead author Joseph Quinn, associate professor of neurology at Oregon Health and Science University and the Portland VA Medical Center. He presented findings Tuesday at the National Press Club.
"We wanted to see if we could slow the rate of progression, and we could not," says Quinn, whose randomized, controlled trial tracked 402 people with mild to moderate Alzheimer's.
"It's looking less good, but we can't answer if they were exposed at midlife if it would have made a difference," says Kristine Yaffe of the University of California-San Francisco and the Veterans Affairs Medical Center, who wrote an accompanying editorial.
That's too bad, but keep the test going. Alzheimer is a very nasty condition not only for these who suffer from it but for the caregivers as well.
No comments:
Post a Comment